$MMATQ
META MATERIALS INC.

2023 Q2 Form 10-Q Financial Statement

#000095017023021728 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $2.031M $1.412M
YoY Change -38.91% -52.52%
Cost Of Revenue $773.0K $741.0K
YoY Change -11.96% -4.85%
Gross Profit $1.258M $671.3K
YoY Change -48.58% -69.43%
Gross Profit Margin 61.93% 47.53%
Selling, General & Admin $6.694M $12.71M
YoY Change -57.08% -18.7%
% of Gross Profit 532.27% 1893.55%
Research & Development $5.060M $6.519M
YoY Change -22.05% 64.17%
% of Gross Profit 402.34% 971.2%
Depreciation & Amortization $1.600M $1.500M
YoY Change -12.15% 98.69%
% of Gross Profit 127.23% 223.45%
Operating Expenses $295.9M $19.23M
YoY Change 1239.87% -1.91%
Operating Profit -$294.7M -$18.56M
YoY Change 1400.3% 6.61%
Interest Expense $4.522K $113.0K
YoY Change -100.41% -31.28%
% of Operating Profit
Other Income/Expense, Net $417.7K -$406.2K
YoY Change -223.96% -60.39%
Pretax Income -$294.3M -$18.97M
YoY Change 1295.13% 2.88%
Income Tax -$618.1K -$296.7K
% Of Pretax Income
Net Earnings -$293.7M -$18.70M
YoY Change 1299.5% 1.44%
Net Earnings / Revenue -14461.95% -1324.12%
Basic Earnings Per Share -$0.65 -$0.05
Diluted Earnings Per Share -$0.65 -$0.05
COMMON SHARES
Basic Shares Outstanding 467.2M 382.2M
Diluted Shares Outstanding 452.8M 368.9M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.96M $6.033M
YoY Change -74.55% -79.72%
Cash & Equivalents $13.96M $6.033M
Short-Term Investments
Other Short-Term Assets $544.4K $339.5K
YoY Change -99.29% -99.56%
Inventory $477.2K $459.6K
Prepaid Expenses $1.352M $3.066M
Receivables $1.251M $837.8K
Other Receivables $8.722K $621.2K
Total Short-Term Assets $19.83M $16.48M
YoY Change -85.1% -84.88%
LONG-TERM ASSETS
Property, Plant & Equipment $47.68M $43.67M
YoY Change 20.57% 45.67%
Goodwill $281.9M
YoY Change 17.1%
Intangibles $53.91M $54.89M
YoY Change 93.93%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $109.0M $385.9M
YoY Change -70.94% 26.4%
TOTAL ASSETS
Total Short-Term Assets $19.83M $16.48M
Total Long-Term Assets $109.0M $385.9M
Total Assets $128.9M $402.4M
YoY Change -74.65% -2.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.66M $15.77M
YoY Change 1.84% 58.58%
Accrued Expenses $2.002M $986.8K
YoY Change 139.26% 26.05%
Deferred Revenue $743.3K $731.0K
YoY Change 5.15%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $547.3K $655.5K
YoY Change -43.94% 80.25%
Total Short-Term Liabilities $16.76M $18.95M
YoY Change -80.62% -77.62%
LONG-TERM LIABILITIES
Long-Term Debt $3.181M $3.129M
YoY Change 25.15% 7.13%
Other Long-Term Liabilities $6.171M $4.109M
YoY Change 54.29% -5.25%
Total Long-Term Liabilities $3.181M $3.129M
YoY Change -51.37% 7.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.76M $18.95M
Total Long-Term Liabilities $3.181M $3.129M
Total Liabilities $28.61M $29.40M
YoY Change -69.32% -68.23%
SHAREHOLDERS EQUITY
Retained Earnings -$521.8M -$226.2M
YoY Change 54.06%
Common Stock $626.6M $604.1M
YoY Change 29.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.2M $373.0M
YoY Change
Total Liabilities & Shareholders Equity $128.9M $402.4M
YoY Change -74.65% -2.88%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$293.7M -$18.70M
YoY Change 1299.5% 1.44%
Depreciation, Depletion And Amortization $1.600M $1.500M
YoY Change -12.15% 98.69%
Cash From Operating Activities -$10.37M -$15.52M
YoY Change 1.04% -17.2%
INVESTING ACTIVITIES
Capital Expenditures $4.801M $1.694M
YoY Change -166.45% -196.96%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.256M
YoY Change -100.0% -56.46%
Cash From Investing Activities -$4.801M -$437.5K
YoY Change -59.78% -138.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $85.46K
YoY Change -6.75%
Cash From Financing Activities 22.85M 10.66M
YoY Change -50.68% 3776.42%
NET CHANGE
Cash From Operating Activities -10.37M -15.52M
Cash From Investing Activities -4.801M -437.5K
Cash From Financing Activities 22.85M 10.66M
Net Change In Cash 7.688M -5.294M
YoY Change -68.15% -69.46%
FREE CASH FLOW
Cash From Operating Activities -$10.37M -$15.52M
Capital Expenditures $4.801M $1.694M
Free Cash Flow -$15.17M -$17.21M
YoY Change 399.91% 1.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001431959
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36247
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Meta Materials Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-3237581
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
60 Highfield Park Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dartmouth
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NS
CY2023Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
B3A 4R9
CY2023Q1 dei City Area Code
CityAreaCode
902
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
482-5729
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
MMAT
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
467206322
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6032996
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10090858
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
508627
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1720613
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
837832
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
902718
CY2023Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
621150
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2211900
CY2023Q1 us-gaap Inventory Net
InventoryNet
459619
CY2022Q4 us-gaap Inventory Net
InventoryNet
468027
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8008047
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7202099
CY2023Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
8521
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
8461
CY2023Q1 us-gaap Assets Current
AssetsCurrent
16476792
CY2022Q4 us-gaap Assets Current
AssetsCurrent
22604676
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
54894466
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56313317
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43668481
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42674699
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5380817
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5576824
CY2023Q1 us-gaap Goodwill
Goodwill
281945633
CY2022Q4 us-gaap Goodwill
Goodwill
281748466
CY2023Q1 us-gaap Assets
Assets
402366189
CY2022Q4 us-gaap Assets
Assets
408917982
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15770279
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16694211
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
655485
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
483226
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
730952
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
730501
CY2023Q1 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
805207
CY2022Q4 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
799490
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
986811
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
967126
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
18948734
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19674554
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
475628
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
479808
CY2023Q1 mmat Deferred Government Assistance Amount Noncurrent
DeferredGovernmentAssistanceAmountNoncurrent
388455
CY2022Q4 mmat Deferred Government Assistance Amount Noncurrent
DeferredGovernmentAssistanceAmountNoncurrent
319017
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3022870
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3253985
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3244799
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3375031
CY2023Q1 us-gaap Contractual Obligation
ContractualObligation
186352
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
180705
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3129219
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3070729
CY2023Q1 us-gaap Liabilities
Liabilities
29396057
CY2022Q4 us-gaap Liabilities
Liabilities
30353829
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
383744889
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
383744889
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
362247867
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
362247867
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
361922
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
340425
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
603693239
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
590962866
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4920023
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5242810
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226165006
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-207496328
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
372970132
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
378564153
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
402366189
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
408917982
CY2023Q1 us-gaap Revenues
Revenues
1412259
CY2022Q1 us-gaap Revenues
Revenues
2974695
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
740980
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
778712
CY2023Q1 us-gaap Gross Profit
GrossProfit
671279
CY2022Q1 us-gaap Gross Profit
GrossProfit
2195983
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2525446
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1035986
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10185571
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14597913
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6519464
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3971139
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
19230481
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
19605038
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18559202
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-17409055
CY2023Q1 us-gaap Interest Expense
InterestExpense
112998
CY2022Q1 us-gaap Interest Expense
InterestExpense
164434
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
284911
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
148391
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-578120
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1009443
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-406207
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1025486
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18965409
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18434541
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-296731
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18668678
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18434541
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
322787
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
905382
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3995442
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
322787
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
905382
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18345891
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17529159
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
368879341
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
368879341
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
285224469
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
285224469
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
378564153
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18668678
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
322787
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10477069
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
438785
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
711246
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2002340
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
372970132
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334708115
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18434541
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
905382
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
197167
CY2022Q1 mmat Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
169575
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4191984
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
321737682
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18668678
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18434541
CY2022Q1 mmat Noncash Finance Income
NoncashFinanceIncome
12920
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
137657
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
126714
CY2023Q1 mmat Non Cash Interest Income
NonCashInterestIncome
391111
CY2023Q1 mmat Non Cash Lease Expense
NonCashLeaseExpense
401528
CY2022Q1 mmat Non Cash Lease Expense
NonCashLeaseExpense
240548
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-296731
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3244511
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1672969
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-18843
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
981861
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
221535
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
140902
CY2023Q1 mmat Adjustments In Contract With Customer Liability
AdjustmentsInContractWithCustomerLiability
-4580
CY2022Q1 mmat Adjustments In Contract With Customer Liability
AdjustmentsInContractWithCustomerLiability
-79146
CY2022Q1 mmat Government Assistance
GovernmentAssistance
3047
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2002343
CY2022Q1 mmat Non Cash Consulting Expense
NonCashConsultingExpense
196541
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
2724270
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
6306857
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15520162
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18745199
CY2023Q1 mmat Payments For Proceeds From Property And Equipment
PaymentsForProceedsFromPropertyAndEquipment
1693768
CY2022Q1 mmat Payments For Proceeds From Property And Equipment
PaymentsForProceedsFromPropertyAndEquipment
1746936
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
2884999
CY2023Q1 mmat Proceeds From Below Market Capital Government Loan
ProceedsFromBelowMarketCapitalGovernmentLoan
256240
CY2023Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1000000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-437528
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1138063
CY2023Q1 mmat Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
10477069
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
438785
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
85457
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
91641
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
711246
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
197167
CY2022Q1 mmat Proceeds From Broker Warrants Exercises
ProceedsFromBrokerWarrantsExercises
169575
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10664073
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
275101
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5293617
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17332035
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11811471
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47434472
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-23769
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126233
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6541623
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30228670
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1998469
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1772821
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
146822
CY2023Q1 mmat Number Of Active Patent Documents
NumberOfActivePatentDocuments
500
CY2023Q1 mmat Number Of Patents Have Issued
NumberOfPatentsHaveIssued
315
CY2023Q1 us-gaap Substantial Doubt About Going Concern Managements Evaluation
SubstantialDoubtAboutGoingConcernManagementsEvaluation
Our evaluation entails analyzing prospective operating budgets and forecasts for expectations of our cash needs and comparing those needs to the current cash and cash equivalent balances.
CY2023Q1 us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18700000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79100000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226200000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
479698
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
490077
CY2023Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
10914
CY2022Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
11345
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
54061
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
51589
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42091
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42058
CY2023Q1 mmat Inventory Provision
InventoryProvision
127145
CY2022Q4 mmat Inventory Provision
InventoryProvision
127042
CY2023Q1 us-gaap Inventory Net
InventoryNet
459619
CY2022Q4 us-gaap Inventory Net
InventoryNet
468027
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3065930
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2835660
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
339513
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
365583
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4602604
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4000856
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8008047
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7202099
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55430276
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52954295
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11761795
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10279596
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43668481
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42674699
CY2023Q1 us-gaap Depreciation
Depreciation
1500000
CY2022Q1 us-gaap Depreciation
Depreciation
800000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
66231887
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
65811004
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11337421
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9497687
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54894466
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56313317
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2022Q4 us-gaap Goodwill
Goodwill
281748466
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
197167
CY2023Q1 us-gaap Goodwill
Goodwill
281945633
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
3784704
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
3553955
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
655485
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
483226
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3129219
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3070729
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
33595044
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.80
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M21D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17611251
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2634244
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.27
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
150254
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.23
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30810546
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.85
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y5M4D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2291214
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24032721
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.78
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y4M9D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2092965
CY2023Q1 mmat Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOutstanding
30810546
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24032721
CY2022Q4 mmat Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOutstanding
33595044
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24327577
CY2023Q1 mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
300000
CY2022Q1 mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
0
CY2022Q1 mmat Increase Decrease In Due From To Related Parties Current
IncreaseDecreaseInDueFromToRelatedPartiesCurrent
54051
CY2023Q1 mmat Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
0
CY2022Q1 mmat Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
56
CY2023Q1 mmat Net Loss
NetLoss
-18668678
CY2022Q1 mmat Net Loss
NetLoss
-18434541
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
368879341
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
285224469
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
368879341
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
285224469
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
79754638
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37868293
CY2023Q1 mmat Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
0
CY2022Q1 mmat Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-146950
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8812
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
96285
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-66159
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
821774
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
792684
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
342711
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1687578
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-5062908
CY2023Q1 mmat Increase Decrease In Due From To Related Parties Current
IncreaseDecreaseInDueFromToRelatedPartiesCurrent
60
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-318919
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-76022
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
2724270
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
6306857
CY2023Q1 us-gaap Contractual Obligation
ContractualObligation
186352
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
180705
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
3784704
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
3553955
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1412259
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2974695
CY2021Q4 mmat Development Contract Value
DevelopmentContractValue
41500000
CY2021 mmat Development Contract Period Maximum
DevelopmentContractPeriodMaximum
P5Y
CY2022Q4 mmat Development Contract Value
DevelopmentContractValue
4300000
CY2023Q1 mmat Number Of Lease Agreements
NumberOfLeaseAgreements
0
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
400450
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
515770
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
79563
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
92259
CY2023Q1 mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
66528
CY2022Q1 mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
60428
CY2023Q1 us-gaap Lease Cost
LeaseCost
546541
CY2022Q1 us-gaap Lease Cost
LeaseCost
668457
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
948054
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1269852
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1159813
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1001885
CY2023Q1 mmat Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
2924616
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7304220
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3072610
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4231610
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
986811
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3244799
CY2023Q1 mmat Number Of Patents
NumberOfPatents
6
CY2023Q1 us-gaap Royalty Expense
RoyaltyExpense
0
CY2022Q1 us-gaap Royalty Expense
RoyaltyExpense
0
CY2022Q3 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
11642
CY2022Q3 mmat Contractual Obligation Lease Term
ContractualObligationLeaseTerm
P132M
CY2022Q3 mmat Contractual Obligation Option To Renew Lease For Additional Term
ContractualObligationOptionToRenewLeaseForAdditionalTerm
P5Y
CY2022Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
12655
CY2022Q4 mmat Contractual Obligation Option To Renew Lease For Additional Term
ContractualObligationOptionToRenewLeaseForAdditionalTerm
P5Y
CY2023Q1 mmat Annual Lease Payments Per Square Foot In Lease Year One
AnnualLeasePaymentsPerSquareFootInLeaseYearOne
18.00
CY2022Q4 mmat Annual Lease Payments Per Square Foot In Lease Year Two
AnnualLeasePaymentsPerSquareFootInLeaseYearTwo
18.50
CY2023Q1 mmat Annual Lease Payments Per Square Foot In Lease Year Three
AnnualLeasePaymentsPerSquareFootInLeaseYearThree
19.00
CY2023Q1 mmat Annual Lease Payments Per Square Foot In Lease Year Four
AnnualLeasePaymentsPerSquareFootInLeaseYearFour
19.50
CY2023Q1 mmat Annual Lease Payments Per Square Foot In Lease Year Five
AnnualLeasePaymentsPerSquareFootInLeaseYearFive
20.00
CY2023Q1 mmat Event Market Price Description
EventMarketPriceDescription
“Event Market Price” means, with respect to any Share Combination Event Date, the quotient determined by dividing (x) the sum of the volume weighted average price of the shares of common stock for each of the five trading days following such Share Combination Event divided by (y) five.

Files In Submission

Name View Source Status
0000950170-23-021728-index-headers.html Edgar Link pending
0000950170-23-021728-index.html Edgar Link pending
0000950170-23-021728.txt Edgar Link pending
0000950170-23-021728-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mmat-20230331.htm Edgar Link pending
mmat-20230331.xsd Edgar Link pending
mmat-ex31_1.htm Edgar Link pending
mmat-ex31_2.htm Edgar Link pending
mmat-ex32_1.htm Edgar Link pending
mmat-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
mmat-20230331_cal.xml Edgar Link unprocessable
mmat-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
mmat-20230331_lab.xml Edgar Link unprocessable
mmat-20230331_pre.xml Edgar Link unprocessable
mmat-20230331_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending